- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.58 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x NA: SODIUM ION(Non-functional Binders)
- 8 x CA: CALCIUM ION(Non-covalent)
CA.2: 4 residues within 4Å:- Chain A: E.52, N.54, V.57, E.62
6 PLIP interactions:4 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:E.52, A:N.54, A:V.57, A:E.62, H2O.1, H2O.2
CA.12: 5 residues within 4Å:- Chain B: Q.31, T.32
- Chain H: Q.31, T.32
- Ligands: CA.66
No protein-ligand interaction detected (PLIP)CA.20: 4 residues within 4Å:- Chain C: E.52, N.54, V.57, E.62
6 PLIP interactions:4 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:E.52, C:N.54, C:V.57, C:E.62, H2O.11, H2O.12
CA.30: 5 residues within 4Å:- Chain D: Q.31, T.32
- Chain F: Q.31, T.32
- Ligands: CA.48
No protein-ligand interaction detected (PLIP)CA.38: 4 residues within 4Å:- Chain E: E.52, N.54, V.57, E.62
6 PLIP interactions:4 interactions with chain E, 2 Ligand-Water interactions- Metal complexes: E:E.52, E:N.54, E:V.57, E:E.62, H2O.22, H2O.23
CA.48: 5 residues within 4Å:- Chain D: Q.31, T.32
- Chain F: Q.31, T.32
- Ligands: CA.30
No protein-ligand interaction detected (PLIP)CA.56: 4 residues within 4Å:- Chain G: E.52, N.54, V.57, E.62
6 PLIP interactions:4 interactions with chain G, 2 Ligand-Water interactions- Metal complexes: G:E.52, G:N.54, G:V.57, G:E.62, H2O.32, H2O.33
CA.66: 5 residues within 4Å:- Chain B: Q.31, T.32
- Chain H: Q.31, T.32
- Ligands: CA.12
No protein-ligand interaction detected (PLIP)- 32 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 3 residues within 4Å:- Chain A: K.149, P.153, G.154
Ligand excluded by PLIPSO4.4: 4 residues within 4Å:- Chain A: K.43, S.44
- Chain B: K.46
- Chain D: K.46
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain B: F.4, E.7, K.41, R.42
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain B: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.15: 4 residues within 4Å:- Chain B: R.1, R.42
- Chain C: K.69, K.89
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain B: P.9, Y.10, T.11, G.12
Ligand excluded by PLIPSO4.17: 4 residues within 4Å:- Chain B: R.1
- Chain C: K.91, S.92, A.93
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain B: R.1
- Chain C: Q.33, K.89
Ligand excluded by PLIPSO4.21: 3 residues within 4Å:- Chain C: K.149, P.153, G.154
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain B: K.46
- Chain C: K.43, S.44
- Chain D: K.46
Ligand excluded by PLIPSO4.31: 4 residues within 4Å:- Chain D: F.4, E.7, K.41, R.42
Ligand excluded by PLIPSO4.32: 4 residues within 4Å:- Chain D: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.33: 4 residues within 4Å:- Chain A: K.69, K.89
- Chain D: R.1, R.42
Ligand excluded by PLIPSO4.34: 4 residues within 4Å:- Chain D: P.9, Y.10, T.11, G.12
Ligand excluded by PLIPSO4.35: 4 residues within 4Å:- Chain A: K.91, S.92, A.93
- Chain D: R.1
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain A: Q.33, K.89
- Chain D: R.1
Ligand excluded by PLIPSO4.39: 3 residues within 4Å:- Chain E: K.149, P.153, G.154
Ligand excluded by PLIPSO4.40: 4 residues within 4Å:- Chain E: K.43, S.44
- Chain F: K.46
- Chain H: K.46
Ligand excluded by PLIPSO4.49: 4 residues within 4Å:- Chain F: F.4, E.7, K.41, R.42
Ligand excluded by PLIPSO4.50: 4 residues within 4Å:- Chain F: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.51: 4 residues within 4Å:- Chain F: R.1, R.42
- Chain G: K.69, K.89
Ligand excluded by PLIPSO4.52: 4 residues within 4Å:- Chain F: P.9, Y.10, T.11, G.12
Ligand excluded by PLIPSO4.53: 4 residues within 4Å:- Chain F: R.1
- Chain G: K.91, S.92, A.93
Ligand excluded by PLIPSO4.54: 3 residues within 4Å:- Chain F: R.1
- Chain G: Q.33, K.89
Ligand excluded by PLIPSO4.57: 3 residues within 4Å:- Chain G: K.149, P.153, G.154
Ligand excluded by PLIPSO4.58: 4 residues within 4Å:- Chain F: K.46
- Chain G: K.43, S.44
- Chain H: K.46
Ligand excluded by PLIPSO4.67: 4 residues within 4Å:- Chain H: F.4, E.7, K.41, R.42
Ligand excluded by PLIPSO4.68: 4 residues within 4Å:- Chain H: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.69: 4 residues within 4Å:- Chain E: K.69, K.89
- Chain H: R.1, R.42
Ligand excluded by PLIPSO4.70: 4 residues within 4Å:- Chain H: P.9, Y.10, T.11, G.12
Ligand excluded by PLIPSO4.71: 4 residues within 4Å:- Chain E: K.91, S.92, A.93
- Chain H: R.1
Ligand excluded by PLIPSO4.72: 3 residues within 4Å:- Chain E: Q.33, K.89
- Chain H: R.1
Ligand excluded by PLIP- 28 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 4 residues within 4Å:- Chain A: T.80, L.81, Q.155, W.193
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: P.132, D.133, V.134, K.136
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: N.77, T.80, N.82
Ligand excluded by PLIPEDO.8: 5 residues within 4Å:- Chain A: C.109, A.110, F.161, Q.188, K.208
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: Y.5, C.7, T.11, L.117
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: S.32, A.94, S.95, L.96
Ligand excluded by PLIPEDO.11: 4 residues within 4Å:- Chain A: I.30, N.31, L.105, K.217
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain C: T.80, L.81, Q.155, W.193
Ligand excluded by PLIPEDO.24: 4 residues within 4Å:- Chain C: P.132, D.133, V.134, K.136
Ligand excluded by PLIPEDO.25: 3 residues within 4Å:- Chain C: N.77, T.80, N.82
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain C: C.109, A.110, F.161, Q.188, K.208
Ligand excluded by PLIPEDO.27: 4 residues within 4Å:- Chain C: Y.5, C.7, T.11, L.117
Ligand excluded by PLIPEDO.28: 4 residues within 4Å:- Chain C: S.32, A.94, S.95, L.96
Ligand excluded by PLIPEDO.29: 4 residues within 4Å:- Chain C: I.30, N.31, L.105, K.217
Ligand excluded by PLIPEDO.41: 4 residues within 4Å:- Chain E: T.80, L.81, Q.155, W.193
Ligand excluded by PLIPEDO.42: 4 residues within 4Å:- Chain E: P.132, D.133, V.134, K.136
Ligand excluded by PLIPEDO.43: 3 residues within 4Å:- Chain E: N.77, T.80, N.82
Ligand excluded by PLIPEDO.44: 5 residues within 4Å:- Chain E: C.109, A.110, F.161, Q.188, K.208
Ligand excluded by PLIPEDO.45: 4 residues within 4Å:- Chain E: Y.5, C.7, T.11, L.117
Ligand excluded by PLIPEDO.46: 4 residues within 4Å:- Chain E: S.32, A.94, S.95, L.96
Ligand excluded by PLIPEDO.47: 4 residues within 4Å:- Chain E: I.30, N.31, L.105, K.217
Ligand excluded by PLIPEDO.59: 4 residues within 4Å:- Chain G: T.80, L.81, Q.155, W.193
Ligand excluded by PLIPEDO.60: 4 residues within 4Å:- Chain G: P.132, D.133, V.134, K.136
Ligand excluded by PLIPEDO.61: 3 residues within 4Å:- Chain G: N.77, T.80, N.82
Ligand excluded by PLIPEDO.62: 5 residues within 4Å:- Chain G: C.109, A.110, F.161, Q.188, K.208
Ligand excluded by PLIPEDO.63: 4 residues within 4Å:- Chain G: Y.5, C.7, T.11, L.117
Ligand excluded by PLIPEDO.64: 4 residues within 4Å:- Chain G: S.32, A.94, S.95, L.96
Ligand excluded by PLIPEDO.65: 4 residues within 4Å:- Chain G: I.30, N.31, L.105, K.217
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zakharova, E. et al., Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor. J.Mol.Biol. (2008)
- Release Date
- 2006-01-24
- Peptides
- Cationic trypsin: ACEG
Pancreatic trypsin inhibitor: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EC
EE
EG
EB
ID
IF
IH
I
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.58 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x NA: SODIUM ION(Non-functional Binders)
- 8 x CA: CALCIUM ION(Non-covalent)
- 32 x SO4: SULFATE ION(Non-functional Binders)
- 28 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zakharova, E. et al., Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor. J.Mol.Biol. (2008)
- Release Date
- 2006-01-24
- Peptides
- Cationic trypsin: ACEG
Pancreatic trypsin inhibitor: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EC
EE
EG
EB
ID
IF
IH
I